US 9446048
Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins
granted A61KA61K31/203A61K31/40
Quick answer
US patent 9446048 (Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/203, A61K31/40, A61K31/417, A61K31/5513